SHERRINGTON ROBIN

Insider Reports History

Location
Burnaby, British Columbia, Canada
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SHERRINGTON ROBIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. EVP, Strategy & Innovation Common Shares 8,398 $388,827 $46.30 07 Mar 2024 Direct
Xenon Pharmaceuticals Inc. EVP, Strategy & Innovation Stock Option (Right to Buy) 65,000 11 Mar 2024 Direct

Insider Reports Filed by SHERRINGTON ROBIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XENE Xenon Pharmaceuticals Inc. 11 Mar 2024 1 $0 4 EVP, Strategy & Innovation 12 Mar 2024, 18:35
XENE Xenon Pharmaceuticals Inc. 07 Mar 2024 8 -$314,300 4 EVP, Strategy & Innovation 08 Mar 2024, 17:31
XENE Xenon Pharmaceuticals Inc. 29 Dec 2023 1 $0 4 EVP, Strategy & Innovation 02 Jan 2024, 16:41
XENE Xenon Pharmaceuticals Inc. 10 Mar 2023 1 $0 4 EVP, Strategy & Innovation 14 Mar 2023, 16:46
XENE Xenon Pharmaceuticals Inc. 31 Aug 2022 11 -$2,488,152 4 EVP, Strategy & Innovation 02 Sep 2022, 16:27
XENE Xenon Pharmaceuticals Inc. 10 Mar 2022 1 $0 4 EVP, Strategy & Innovation 14 Mar 2022, 16:21
XENE Xenon Pharmaceuticals Inc. 04 Mar 2022 9 -$656,896 4 EVP, Strategy & Innovation 08 Mar 2022, 18:35
XENE Xenon Pharmaceuticals Inc. 28 May 2021 8 -$95,938 4 EVP, Strategy & Innovation 01 Jun 2021, 16:11